Schedule II - Valuation And Qualifying Accounts

12 Months Ended

Dec. 31, 2014

Schedule II - Valuation And Qualifying Accounts [Abstract]

Schedule II - Valuation And Qualifying Accounts

SCHEDULE II – VALUATION AND QUALIFYING ACCOUNTS

SCICLONE PHARMACEUTICALS, INC.

Receivables and Product Returns Reserves (in thousands):

	Balance at		Charges for			Deductions for		Deductions for		Balance at
	Beginning of		Amounts			Amounts		Amounts		End of
	Period		Reserved			Recovered		Written Off		Period
Receivables Reserve:
Year Ended December 31, 2014	$	(3,587)	$	—		$	1,500	$	1,089	$	(998)
Year Ended December 31, 2013	$	(1,046)	$	(2,541)	(1)	$	—	$	—	$	(3,587)
Year Ended December 31, 2012	$	—	$	(1,046)	(2)	$	—	$	—	$	(1,046)
Reserve for Product Returns:
Year Ended December 31, 2014	$	—	$	(66)		$	—	$	—	$	(66)
Year Ended December 31, 2013	$	(123)	$	—		$	123	$	—	$	—
Year Ended December 31, 2012	$	(116)	$	(58)		$	51	$	—	$	(123)

(1) For the year ended December 31, 2013, the charges for amounts reserved included $2.5 million of general and administrative expense related to bad debt that was uncertain of collection.

(2) For the year ended December 31, 2012, the charges for amounts reserved included $1.0 million recorded as a reduction in product revenue relating to price concessions that were recorded to the accounts receivable reserve.